The Patent Finder

Umd, Inc.

Also on record
Records under this name other than patents Umd, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Umd, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,527,614Protective Tube for a Medicated Tampon
Formerly held
Term ended
Ended no later than Jan 30, 2026 · Medium confidence
Term endedEnded no later than Jan 30, 2026Medium confidence
US 7,939,098Compositions and method for transmucosal drug delivery and cryoprotection
Formerly held
Lapsed on the fee record
Ended May 10, 2019 · USPTO record
Lapsed on the fee recordEnded May 10, 2019USPTO record
US 6,086,909Device and method for treatment of dysmenorrhea
Formerly held
Term ended
Term ended Feb 12, 2019 · USPTO record
Term endedTerm ended Feb 12, 2019USPTO record
US 7,744,916Coated vaginal device for delivery of anti-migraine and anti-nausea drugs
Formerly held
Lapsed on the fee record
Ended Jun 29, 2018 · USPTO record
Lapsed on the fee recordEnded Jun 29, 2018USPTO record
US 6,197,327Device and method for treatment of dysmenorrhea
Formerly held
Term ended
Term ended May 15, 2018 · USPTO record
Term endedTerm ended May 15, 2018USPTO record
US 7,341,737Medicated Tampon
Formerly held
Term ended
Term ended May 15, 2018 · Medium confidence
Term endedTerm ended May 15, 2018Medium confidence
US 6,982,091Vaginal delivery of chemotherapeutic agents and inhibitors of membrane efflux systems for cancer therapy
Formerly held
Lapsed on the fee record
Ended Jan 3, 2018 · USPTO record
Lapsed on the fee recordEnded Jan 3, 2018USPTO record
US 6,905,701Formulations for transmucosal vaginal delivery of bisphosphonates
Formerly held
Lapsed on the fee record
Ended Jun 14, 2017 · USPTO record
Lapsed on the fee recordEnded Jun 14, 2017USPTO record
US 8,178,123Method for augmentation of intraepithelial and systemic exposure of therapeutic agents having substrate activity for cytochrome P450 enzymes and membrane efflux systems following vaginal and oral cavity administration
Formerly held
Lapsed on the fee record
Ended May 15, 2016 · USPTO record
Lapsed on the fee recordEnded May 15, 2016USPTO record
US 6,572,874Vaginal delivery of bisphosphonates
Formerly held
Lapsed on the fee record
Ended Jun 3, 2015 · USPTO record
Lapsed on the fee recordEnded Jun 3, 2015USPTO record
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited